Riskpilot← Back to searchSign inGet full accessFysioDanmark Holstebro ApS
APSActiveCVR 32338313Sønderlandsgade 9Physiotherapy activities · NACE 8695Est. 201320 employees
Revenue 2025
DKK 7,6M
-10% vs 2024
EBITDA margin
20.6%
-31% vs 2024
Equity ratio
35.9%
Financial strength
Net profit 2025
DKK 1,3M
-26% vs 2024
| Revenue | DKK 7,6M | -10% |
| EBITDA | DKK 1,6M | -31% |
| Net profit | DKK 1,3M | -26% |
| Total assets | DKK 7,3M | +60% |
| Equity | DKK 2,6M | -8% |
| Employees | 20 | — |
Legal name
FysioDanmark Holstebro ApS
CVR number
32338313
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
26. juni 2013
Share capital
DKK 125.000
Employees
20 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er at udøve virksomhed med fysioterapi og dertil naturligt knyttede ydelser.
Address
Sønderlandsgade 9
Phone
+4597427999
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.896 | 1.969 | 2.685 | 4.085 | 4.745 | 5.194 | 5.095 | 4.421 | 6.720 | 8.285 | 8.116 | 8.472 | 7.618 |
| Staff expenses | -1.817 | -441 | -537 | -2.024 | -2.227 | -2.343 | -2.791 | -2.718 | -4.855 | -5.505 | -5.466 | -6.202 | -6.045 |
| EBITDA | 345 | 1.527 | 2.148 | 2.061 | 2.517 | 2.851 | 2.304 | 1.703 | 1.865 | 2.780 | 2.650 | 2.270 | 1.573 |
| Depreciation & amort. | -475 | 517 | -586 | -826 | -750 | -672 | -663 | -639 | -344 | -335 | -342 | -349 | -182 |
| EBIT | -130 | 1.010 | 1.562 | 1.234 | 1.767 | 2.179 | 1.641 | 1.064 | 1.520 | 2.445 | 2.308 | 1.921 | 1.391 |
| Net financials | -14 | -5 | 30 | 36 | 29 | 54 | -4 | -27 | -45 | -7 | 58 | 241 | 208 |
| Profit before tax | -144 | 1.005 | 1.585 | 1.229 | 1.793 | 2.228 | 1.631 | 1.037 | 1.475 | 2.438 | 2.366 | 2.162 | 1.599 |
| Tax | 133 | 190 | 380 | 272 | 397 | 493 | 375 | 212 | 343 | 541 | 517 | 432 | 313 |
| Net profit | -277 | 815 | 1.205 | 957 | 1.396 | 1.735 | 1.256 | 825 | 1.131 | 1.897 | 1.849 | 1.730 | 1.286 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.864 | 3.964 | 5.061 | 6.384 | 6.032 | 5.061 | 4.351 | 6.159 | 4.190 | 4.367 | 4.879 | 4.572 | 7.314 |
| Equity | 2.690 | 2.778 | 3.383 | 4.659 | 4.609 | 3.470 | 766 | 1.591 | 1.323 | 2.357 | 3.106 | 2.836 | 2.622 |
| Long-term debt | 0 | 0 | 163 | 0 | 0 | 0 | 1.123 | 1.719 | 313 | 0 | 0 | 0 | 0 |
| Short-term debt | 419 | 551 | 952 | 1.221 | 985 | 1.210 | 2.142 | 2.583 | 2.264 | 1.706 | 1.511 | 1.516 | 4.479 |
| Total debt | 419 | 551 | 1.115 | 1.221 | 985 | 1.210 | 3.265 | 4.302 | 2.577 | 1.706 | 1.511 | 1.516 | 4.479 |
EBITDA margin
20.6%
This company
15.8%
Market median
+30% vs market
20132025
Equity ratio
35.9%
This company
38.2%
Market median
+6% vs market
20132025
Return on equity
49.1%
This company
18.4%
Market median
+167% vs market
20132025
Net profit margin
16.9%
This company
8.1%
Market median
+109% vs market
20132025
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
20132025
Debt / equity
1.79×
This company
0.62×
Market median
-189% vs market
20132025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LD Founder | Founder | 2013 | — | — |
KB Management | Management | 2013 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KK 2916 Holding ApS | Company | 33.3% | 33.3% | 2023 |
M. VANGGAARD HOLDING ApS | Company | 20.0% | 20.0% | 2023 |
Bay Holding, Holstebro ApS | Company | 15.0% | 15.0% | 2023 |
SMS Holding, Holstebro ApS | Company | 15.0% | 15.0% | 2023 |
FYSIO SØNDERLAND AUTORISEREDE FYSIOTERAPEUTER HOLDING ApS | Company | 50.0% | 50.0% | 2016 |
L D Holding ApS | Company | 25.0% | 25.0% | 2016 |
FysioDanmark Holstebro ApS | Company | 15.0% | 15.0% | 2019 |
JL Autoriseret Fysioterapeut Holding ApS | Company | 25.0% | 25.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
M. VANGGAARD HOLDING ApS
FysioDanmark Holstebro ApS Board members of FysioDanmark Holstebro ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lotte Dahlgaard | Founder | 0 companies |
| Klaus Bang Carstensen | Management | 0 companies |